Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $56.7 million.

  • Icu Medical's Cash from Operations rose 5710.45% to $56.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.4 million, marking a year-over-year decrease of 3750.15%. This contributed to the annual value of $204.0 million for FY2024, which is 2276.28% up from last year.
  • Latest data reveals that Icu Medical reported Cash from Operations of $56.7 million as of Q3 2025, which was up 5710.45% from $11.2 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Cash from Operations registered a high of $91.3 million during Q4 2023, and its lowest value of -$61.4 million during Q2 2022.
  • Moreover, its 5-year median value for Cash from Operations was $41.2 million (2023), whereas its average is $36.6 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first crashed by 21209.42% in 2022, then skyrocketed by 565990.5% in 2024.
  • Icu Medical's Cash from Operations (Quarter) stood at $82.6 million in 2021, then crashed by 102.07% to -$1.7 million in 2022, then surged by 5434.25% to $91.3 million in 2023, then plummeted by 55.96% to $40.2 million in 2024, then surged by 41.1% to $56.7 million in 2025.
  • Its Cash from Operations was $56.7 million in Q3 2025, compared to $11.2 million in Q2 2025 and $51.3 million in Q1 2025.